KRR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.33360000212457E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.24389999999852E-05 |
Normal-vs-Stage2 |
2.121900E-03 |
Normal-vs-Stage3 |
7.83550002658728E-10 |
Normal-vs-Stage4 |
1.9243999727081E-09 |
Stage1-vs-Stage2 |
6.910200E-01 |
Stage1-vs-Stage3 |
1.798590E-03 |
Stage1-vs-Stage4 |
2.799700E-03 |
Stage2-vs-Stage3 |
1.613960E-01 |
Stage2-vs-Stage4 |
1.315960E-01 |
Stage3-vs-Stage4 |
8.195800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.64229999786303E-08 |
Normal-vs-AfricanAmerican |
2.58739999980939E-07 |
Normal-vs-Asian |
8.465800E-02 |
Caucasian-vs-AfricanAmerican |
1.619800E-01 |
Caucasian-vs-Asian |
7.957400E-01 |
AfricanAmerican-vs-Asian |
4.147800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.06259994931457E-09 |
Normal-vs-Female |
1.69221999999358E-05 |
Male-vs-Female |
1.154580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.234880E-04 |
Normal-vs-Age(41-60Yrs) |
3.8522999999957E-06 |
Normal-vs-Age(61-80Yrs) |
3.78890000485299E-08 |
Normal-vs-Age(81-100Yrs) |
2.48479999997997E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.347000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.535800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.741600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.400000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.673800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.574030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.584400E-01 |
Normal-vs-Grade 2 |
1.753750E-04 |
Normal-vs-Grade 3 |
1.27029498031561E-11 |
Normal-vs-Grade 4 |
1.15690013124947E-10 |
Grade 1-vs-Grade 2 |
3.146800E-01 |
Grade 1-vs-Grade 3 |
7.861000E-03 |
Grade 1-vs-Grade 4 |
2.602200E-03 |
Grade 2-vs-Grade 3 |
3.580200E-04 |
Grade 2-vs-Grade 4 |
2.044900E-04 |
Grade 3-vs-Grade 4 |
1.158210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.201560E-03 |
Normal-vs-ccB subtype |
4.86760000084629E-08 |
ccA subtype-vs-ccB subtype |
7.197900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.10239999995265E-06 |
Normal-vs-N1 |
3.179700E-03 |
N0-vs-N1 |
6.339400E-01 |
|
|